肺癌に伴う上大静脈症候群に対する 血管内ステント留置15症 …
はEastern Cooperative Oncology Group（ECOG）の分 類で，PS 1～2が12例，PS 3～4が3例であった．ステ ント留置時の肺癌の広がりは，胸郭内での進展例が7例， 胸郭外病変（遠隔転移）のある症例が8例であった． SVC症候群による症状は，14例において顔面や上肢
Download 肺癌に伴う上大静脈症候群に対する 血管内ステント留置15症 …
Information
Domain:
Source:
Link to this page:
Documents from same domain
Topics 5
www.jrs.or.jpTopics 5 ， はじめに 最近，日本で高流量式鼻カニュラが輸入販売され，臨 床で広く使われるようになった．これは，単に低濃度か
急速に進行する間質性肺炎に対する抗凝固療法併用 …
www.jrs.or.jp408 日呼吸会誌 49（6），2011． Fig. 1 Kaplan-Meier survival curves for the anticoag-ulation group (group A) and non-anticoagulation
Topics 6
www.jrs.or.jpTopics 6 Extracorporeal membrane oxygenation （ECMO） 竹田 晋浩a/青景 聡之b 要旨：Extracorporeal membrane oxygenation（ECMO）は急性重症 呼吸不全患者に対して，従来の人工呼吸管理では生命が維持できなく
市中肺炎の重症度分類：PSI，CURB-65 ... - jrs.or.jp
www.jrs.or.jp市中肺炎の重症度分類 783 Table 3 Comparison of the prognostic accu-racy of the pneumonia severity index (PSI), the CURB-65 score and the A-DROP score
< …
www.jrs.or.jp薬生監麻発1227第9号 生食監発 1227第8号 平成28年12月27日 一般社団法人 日本呼吸器学会 理事長 殿
臓側胸膜子宮内膜症による月経随伴性気胸の1例
www.jrs.or.jp臓側胸膜子宮内膜症の月経随伴性気胸 説以外の機序を考えるべきである． 本症例は横隔膜病変がみられず，気胸の原因は臓側胸
防水スプレー吸入後に発症した肺障害の2例 ～肺機 …
www.jrs.or.jp368 日呼吸会誌 47（5），2009． Table 1 Laboratory findings on the first hospital day (Case 1 and Case 2) CBC Blood chemistry Serology Case 1 …
『成人肺炎診療ガイドライン 2017 - jrs.or.jp
www.jrs.or.jp『成人肺炎診療ガイドライン2017』 フローチャート他の訂正とお詫び 『肺炎診療ガイドライン2017』p.ⅲのフローチャートならびにp.4、p.170
非燃焼・加熱式タバコや電子 ... - jrs.or.jp
www.jrs.or.jp3 2. 欅田尚樹．電子タバコ蒸気に含まれる有害化学成分．厚生労働省委員会報告書 http://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-
Topics 3
www.jrs.or.jpTopics 3 日呼吸誌 2（5 ），0 13 ARDS早期からの 線維増殖性病変について これまで，ARDSの臨床病期は，early phaseとlate phaseの2つに分類されてお …
Related documents
Proleukin (aldesleukin) injection label
www.accessdata.fda.govEligible patients had an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0 or 1 and normal organ function as determined by cardiac stress test, pulmonary function tests, and creatinine ≤1.5 mg/dL. Studies excluded patients with brain metastases, active infections, organ allografts and diseases requiring steroid treatment.
Reference ID: 4030092
www.accessdata.fda.govlabel, single arm trials. In these patients, the median age was 62 years (range 31 to 86), 100% had an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, 38% had . BRCA-mutated ovarian cancer, 45% had received 3 or more prior lines of chemotherapy, and the median time since ovarian cancer diagnosis was 43 months (range 6 to ...
ОСНОВЫ КЛИНИЧЕСКОЙ ГЕМАТОЛОГИИ
vrachirf.ruECOG — Eastern Cooperative Oncology Group IPS — International Prognostic Score MALT — mucosa associated lymphoid tumor TF — tissue factor (тканевой фактор) TFPI — Tissue factor pathway inhibitor FISH — fluorescence in situ hybridizations Список сокращений
Diagnosis, Staging, and Management of Hepatocellular ...
www.aasld.orgnual incidence rates in eastern Asia and Sub-Saharan Africa exceed 15 per 100,000 inhabitants, whereas fig - ures are intermediate (between 5 and 15 per 100,000) in the Mediterranean Basin, Southern Europe, and North America and very low (below 5 per 100,000) in Northern Europe.(4) Vaccination against hepati-
Assessment report - Europa
www.ema.europa.euECOG Eastern Cooperative Oncology Group . ELISA Enzyme-Linked Immunosorbent assay . EORTC- QLQ European Organisation for Research and Treatment of Care core Quality of Life . Page 4/160 questionnaire . ERA Environmental Risk Assessment . eGFR Estimated glomerular filtration rate . FAS Full Analysis Set ...
ESPEN guidelines on nutrition in cancer patients
www.espen.infoECOG Eastern Cooperative Oncology Group EAPC European Association for Palliative Care EFSA European Food Safety Authority EN enteral nutrition EPA 20:5 eicosapentaenoic acid ERAS enhanced recovery after surgery ESMO European Society for Medical Oncology FDA U.S. Food and Drug Agency
ACUTE ONCOLOGY INITIAL MANAGEMENT GUIDELINES
www.ukons.orgAlways make sure that the Acute Oncology Team are informed of the patient’s assessment and/or admission as soon as possible. Immediate advice is available from the Acute Oncology Service or the 24 Hour Oncology on call rota. WITHHOLD! SACT, including oral therapy, until you have discussed with the Acute Oncology or Site Specific Team.